These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 32334887)

  • 1. Systematic review and meta-analysis of immune response of double dose of hepatitis B vaccination in HIV-infected patients.
    Lee JH; Hong S; Im JH; Lee JS; Baek JH; Kwon HY
    Vaccine; 2020 May; 38(24):3995-4000. PubMed ID: 32334887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does increased hepatitis B vaccination dose lead to a better immune response in HIV-infected patients than standard dose vaccination: a meta-analysis?
    Ni JD; Xiong YZ; Wang XJ; Xiu LC
    Int J STD AIDS; 2013 Feb; 24(2):117-22. PubMed ID: 23467291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaccination Against Hepatitis B Virus (HBV) in HIV-1-Infected Patients With Isolated Anti-HBV Core Antibody: The ANRS HB EP03 CISOVAC Prospective Study.
    Piroth L; Launay O; Michel ML; Bourredjem A; Miailhes P; Ajana F; Chirouze C; Zucman D; Wendling MJ; Nazzal D; Carrat F; Rey D; Binquet C;
    J Infect Dis; 2016 Jun; 213(11):1735-42. PubMed ID: 26768256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Higher rate of long-term serologic response of four double doses vs. standard doses of hepatitis B vaccination in HIV-infected adults: 4-year follow-up of a randomised controlled trial.
    Chaiwarith R; Praparattanapan J; Kotarathititum W; Wipasa J; Chaiklang K; Supparatpinyo K
    AIDS Res Ther; 2019 Nov; 16(1):33. PubMed ID: 31711528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunogenicity and safety of 4 vs. 3 standard doses of HBV vaccination in HIV-infected adults with isolated anti-HBc antibody.
    Laksananun N; Praparattanapan J; Kotarathititum W; Supparatpinyo K; Chaiwarith R
    AIDS Res Ther; 2019 May; 16(1):10. PubMed ID: 31053142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis B Virus Vaccination in HIV: Immunogenicity and Persistence of Seroprotection up to 7 Years Following a Primary Immunization Course.
    Nicolini LA; Magne F; Signori A; Di Biagio A; Sticchi L; Paganino C; Durando P; Viscoli C
    AIDS Res Hum Retroviruses; 2018 Nov; 34(11):922-928. PubMed ID: 29926738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term Immune Response to Hepatitis B Virus Vaccination Regimens in Adults With Human Immunodeficiency Virus 1: Secondary Analysis of a Randomized Clinical Trial.
    Launay O; Rosenberg AR; Rey D; Pouget N; Michel ML; Reynes J; Neau D; Raffi F; Piroth L; Carrat F;
    JAMA Intern Med; 2016 May; 176(5):603-10. PubMed ID: 27064975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccination against hepatitis B with 4-double doses increases response rates and antibodies titers in HIV-infected adults.
    Potsch DV; Camacho LA; Tuboi S; Villar LM; Miguel JC; Ginuíno C; Silva EF; Mendonça RM; Moreira RB; Barroso PF
    Vaccine; 2012 Sep; 30(41):5973-7. PubMed ID: 22828589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and immunogenicity of 4 intramuscular double doses and 4 intradermal low doses vs standard hepatitis B vaccine regimen in adults with HIV-1: a randomized controlled trial.
    Launay O; van der Vliet D; Rosenberg AR; Michel ML; Piroth L; Rey D; Colin de Verdière N; Slama L; Martin K; Lortholary O; Carrat F;
    JAMA; 2011 Apr; 305(14):1432-40. PubMed ID: 21486976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccination coverage and immunity against hepatitis B among HIV-infected patients in South Brazil.
    Martins S; Livramento Ad; Andrigueti M; Kretzer IF; Machado MJ; Spada C; Treitinger A
    Braz J Infect Dis; 2015; 19(2):181-6. PubMed ID: 25626960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A double-dose hepatitis B vaccination schedule in travelers presenting for late consultation.
    Wong J; Payne M; Hollenberg S
    J Travel Med; 2014; 21(4):260-5. PubMed ID: 24796543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune Response to Hepatitis B Virus Vaccine Among People Living With HIV: A Meta-Analysis.
    Tian Y; Hua W; Wu Y; Zhang T; Wang W; Wu H; Guo C; Huang X
    Front Immunol; 2021; 12():745541. PubMed ID: 35003061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis B virus vaccine in chronic kidney disease: improved immunogenicity by adjuvants? A meta-analysis of randomized trials.
    Fabrizi F; Dixit V; Messa P; Martin P
    Vaccine; 2012 Mar; 30(13):2295-300. PubMed ID: 22285268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Persistence of Hepatitis B Immunity Following 3-dose Infant Primary Series in HIV-infected Thai Adolescents and Immunologic Response to Revaccination.
    Lapphra K; Angkhananukit P; Saihongthong S; Phongsamart W; Wittawatmongkol O; Rungmaitree S; Chokephaibulkit K
    Pediatr Infect Dis J; 2017 Sep; 36(9):863-868. PubMed ID: 28419007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Poor efficacy of intradermal administration of recombinant hepatitis B virus immunization in HIV-infected individuals who fail to respond to intramuscular administration of hepatitis B virus vaccine.
    Shafran SD; Mashinter LD; Lindemulder A; Taylor GD; Chiu I
    HIV Med; 2007 Jul; 8(5):295-9. PubMed ID: 17561875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV viraemia during hepatitis B vaccination shortens the duration of protective antibody levels.
    O'Bryan TA; Rini EA; Okulicz J; Messner O; Ganesan A; Lalani T; Bavaro MF; O'Connell RJ; Agan BK; Landrum ML
    HIV Med; 2015 Mar; 16(3):161-7. PubMed ID: 25586899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High prevalence of syphilis, HBV, and HCV co-infection, and low rate of effective vaccination against hepatitis B in HIV-infected patients in West China hospital.
    Yang T; Chen Q; Li D; Wang T; Gou Y; Wei B; Tao C
    J Med Virol; 2018 Jan; 90(1):101-108. PubMed ID: 28792076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Seroconverting nonresponder of high-dose intramuscular HBV vaccine with intradermal HBV vaccine: A case report.
    Das M; Vanar V; Martin DK; Walayat S; Patel J; Badshah MB; Kalva NR; Pisoh WN; Dhillon S
    Medicine (Baltimore); 2017 Nov; 96(46):e8575. PubMed ID: 29145268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis B vaccination uptake and correlates of serologic response among HIV-infected and uninfected men who have sex with men (MSM) in Bangkok, Thailand.
    Chonwattana W; Raengsakulrach B; Holtz TH; Wasinrapee P; Tongtoyai J; Chaikummao S; Pattanasin S; McNicholl JM; van Griensven F; Curlin ME
    Vaccine; 2016 Apr; 34(17):2044-50. PubMed ID: 26685092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune response to hepatitis B virus vaccination among HIV-1 infected and uninfected adults in Kenya.
    Irungu E; Mugo N; Ngure K; Njuguna R; Celum C; Farquhar C; Dhanireddy S; Baeten JM
    J Infect Dis; 2013 Feb; 207(3):402-10. PubMed ID: 23175769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.